Association of two polymorphisms Asp299Gly and Thr399Ile in Toll-like receptor 4 with rheumatoid arthritis: A meta-analysis

被引:0
作者
Yan, Shunchao [1 ]
Chen, Haobo [2 ]
Wang, Zixian [3 ]
Zhao, Linshan [1 ]
机构
[1] Henan Univ, Clin Med Coll, Kaifeng, Peoples R China
[2] Henan Univ, Basic Med Coll, Kaifeng, Peoples R China
[3] Henan Univ, Affiliated Hosp 1, Kaifeng, Peoples R China
关键词
meta-analysis; polymorphism; rheumatoid arthritis; single nucleotide polymorphisms; SINGLE NUCLEOTIDE POLYMORPHISMS; SYSTEMIC-SCLEROSIS; GENE; SUSCEPTIBILITY; TOLL-LIKE-RECEPTOR-4; DISEASE; CHINESE; SCLERODERMA; INNATE; RISK;
D O I
10.1111/1756-185X.13890
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Our meta-analysis aims to evaluate the association of Asp299Gly and Thr399Ile with rheumatoid arthritis (RA) susceptibility and severity. By manually searching 3 electronic databases (PubMed, Embase and Web of Science), relevant articles were collected. After checking eligibility for every study, this meta-analysis on eligible studies was performed under 5 genetic models: (1) allelic contrast; (2) heterozygous model; (3) homozygous model; (4) dominant model; (5) recessive model. In Spanish populations, a significantly decreased RA risk was identified in allelic comparison (odds ratio [OR] = 0.73, 95% CI 0.55 similar to 0.96) and dominant model (OR = 0.74, 95% CI 0.56 similar to 0.99) of Asp299Gly polymorphism. A trend of reduced risk was also observed under the heterozygous model (OR = 0.77, 95% CI 0.58 similar to 1.03). As for Thr399Ile, it might also have a protective effect on Spanish populations in allelic comparison (OR = 0.71, 95% CI 0.44 similar to 1.15). In contrast, for both Asp299Gly and Thr399Ile, a higher risk of RA was detected in Chinese Han populations. The frequency of both Asp299Gly and Thr399Ile increased in rheumatoid factor (RF)-positive subjects in Chinese patients (Asp299Gly, RF+:RF- = 0.165:0.145; Thr399Ile, RF+:RF- = 0.170:0.161) and decreased in Spanish patients (Asp299Gly, RF+:RF- = 0.060:0.073; Thr399Ile, RF+:RF- = 0.046:0.056), but not to a statistically significant extent. Our meta-analysis suggested that both Asp299Gly and Thr399Ile might have a protective effect on Spanish populations, but the 2 polymorphisms could act as a susceptible factor in Chinese Han populations. To confirm our results, further investigation concerning the functional impacts of Asp299Gly and Thr399Ile are still needed.
引用
收藏
页码:1117 / 1125
页数:9
相关论文
共 44 条
  • [1] Toll-like receptors: critical proteins linking innate and acquired immunity
    Akira, S
    Takeda, K
    Kaisho, T
    [J]. NATURE IMMUNOLOGY, 2001, 2 (08) : 675 - 680
  • [2] Alvarez-Rodriguez L, 2011, CLIN EXP RHEUMATOL, V29, P795
  • [3] Fibrosis regression induced by intravenous gammaglobulin treatment
    Amital, H
    Rewald, E
    Levy, Y
    Bar-Dayan, Y
    Manthorpe, R
    Engervall, P
    Sherer, Y
    Langevitz, P
    Shoenfeld, Y
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (02) : 175 - 177
  • [4] TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
    Arbour, NC
    Lorenz, E
    Schutte, BC
    Zabner, J
    Kline, JN
    Jones, M
    Frees, K
    Watt, JL
    Schwartz, DA
    [J]. NATURE GENETICS, 2000, 25 (02) : 187 - +
  • [5] OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS
    BEGG, CB
    MAZUMDAR, M
    [J]. BIOMETRICS, 1994, 50 (04) : 1088 - 1101
  • [6] Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association
    Browning, Brian L.
    Huebner, Claudia
    Petermann, Ivonne
    Gearry, Richard B.
    Barclay, Murray L.
    Shelling, Andrew N.
    Ferguson, Lynnette R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (11) : 2504 - 2512
  • [7] Biology of longevity:: Role of the innate immune system
    Candore, G
    Colonna-Romano, G
    Balistreri, CR
    Di Carlo, D
    Grimaldi, MP
    Listì, F
    Nuzzo, D
    Vasto, S
    Lio, D
    Casuso, C
    [J]. REJUVENATION RESEARCH, 2006, 9 (01) : 143 - 148
  • [8] CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892
  • [9] My Treatment Approach to Rheumatoid Arthritis
    Davis, John M., III
    Matteson, Eric L.
    [J]. MAYO CLINIC PROCEEDINGS, 2012, 87 (07) : 659 - 673
  • [10] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188